Denise Bronner on Muck Rack

Denise Bronner

(She/Her)
Irvine
As seen in: Clinical Leader, Life Science Leader
Covers:  healthcare, pharma, entrepreneurship, clinical trials, leadership, DEI, caregiver
Back to Denise Bronner’s profile

Denise Bronner’s Journalist Portfolio

View as a list
Caregivers: The Missing Line Item In Trial Budgets

Caregivers: The Missing Line Item In Trial Budgets

More than 60 million Americans are caregivers, holding up a system and clinical research enterprise, yet they…

View article →
The Cost Of Transactional Thinking In Clinical Research

The Cost Of Transactional Thinking In Clinical Research

Denise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apa…

View article →
The U.S. Trial Advantage Is Eroding

The U.S. Trial Advantage Is Eroding

Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, econom…

View article →
How Government Shutdowns Set Back Clinical Trials

How Government Shutdowns Set Back Clinical Trials

When the federal government shuts down, clinical research suffers. Empactful Ventures Denise N. Bronner, Ph.D…

View article →
FDA Pharma Advertising Crackdown Reshapes Clinical Research, Too

FDA Pharma Advertising Crackdown Reshapes Clinical Research, Too

Empactul Ventures Denise N. Bronner, Ph.D., explores how the FDAs crackdown on pharmaceutical advertising mig…

View article →
How Digital Twins Are Rewriting Clinical Trials

How Digital Twins Are Rewriting Clinical Trials

While the benefits of digital twins to accelerate clinical trials are undeniable, many questions about their …

View article →
Dear Pharma, The Creator Economy Is NOT Only For Beauty

Dear Pharma, The Creator Economy Is NOT Only For Beauty

Empactful Ventures CEO Denise N. Bronner has a message for pharma when it comes to influencer marketing: Adap…

View article →
In The Age Of AI, Data Is Still King

In The Age Of AI, Data Is Still King

While AI captures attention, data quietly runs the show, says Empactful Ventures Founder Denise Bronner, Ph.D…

View article →
Borrowed Brilliance: Is Pharma Becoming Overly Reliant On Acquisitions?

Borrowed Brilliance: Is Pharma Becoming Overly Reliant On Acquisitions?

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She…

View article →
DEI Was Never the Problem, The Way Pharma Did It Was

DEI Was Never the Problem, The Way Pharma Did It Was

Consultant Denise Bronner details pharmas strategic rollback of DEI initiatives, roles, and even departments …

View article →
Why Site-CRO Relationships Are So Strained - And How To Fix Them

Why Site-CRO Relationships Are So Strained - And How To Fix Them

Empactful Ventures Founder Denise Bronner explains the issues that strain site-sponsor relationships and how …

View article →
The DEI Dilemma: Separate Teams Or Embedded Methods?

The DEI Dilemma: Separate Teams Or Embedded Methods?

Denise Bronner, PH.D. examines the advantages and drawbacks of separate, dedicated DEI teams and diversity ro…

View article →
What's Lacking In FDA's Latest Diversity Guidance?

What's Lacking In FDA's Latest Diversity Guidance?

The FDA’s new guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented …

View article →
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified